Novartis AG (NVSEF)
134.53
+0.33
(+0.25%)
USD |
OTCM |
Oct 05, 16:00
Novartis Price : 134.53 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 136.39 | 136.39 | 134.53 | 134.53 | 1242.00 |
| Oct 02, 2026 | 134.20 | 137.40 | 134.20 | 134.20 | 633.00 |
| Oct 01, 2026 | 140.93 | 140.93 | 140.93 | 140.93 | 66148.00 |
| Sep 30, 2026 | 140.93 | 140.93 | 140.93 | 140.93 | 303471.0 |
| Sep 29, 2026 | 139.02 | 144.94 | 139.02 | 144.94 | 100304.0 |
| Sep 28, 2026 | 142.68 | 146.00 | 139.41 | 146.00 | 5925.00 |
| Sep 25, 2026 | 140.96 | 140.96 | 140.96 | 140.96 | 312.00 |
| Sep 24, 2026 | 138.10 | 142.51 | 138.10 | 142.51 | 557.00 |
| Sep 23, 2026 | 138.38 | 138.38 | 138.38 | 138.38 | 213.00 |
| Sep 22, 2026 | 138.38 | 138.38 | 138.38 | 138.38 | 36792.00 |
| Sep 21, 2026 | 140.63 | 140.63 | 138.25 | 138.25 | 289.00 |
| Sep 18, 2026 | 137.12 | 146.75 | 133.70 | 133.70 | 2175.00 |
| Sep 17, 2026 | 142.06 | 142.06 | 142.06 | 142.06 | 167.00 |
| Sep 16, 2026 | 142.06 | 142.06 | 142.06 | 142.06 | 115.00 |
| Sep 15, 2026 | 140.61 | 142.06 | 132.81 | 142.06 | 970.00 |
| Sep 14, 2026 | 137.25 | 137.41 | 134.75 | 134.75 | 2908.00 |
| Sep 11, 2026 | 137.76 | 137.76 | 137.76 | 137.76 | 300459.0 |
| Sep 10, 2026 | 137.38 | 137.95 | 137.38 | 137.95 | 898.00 |
| Sep 09, 2026 | 138.50 | 138.50 | 138.50 | 138.50 | 339.00 |
| Sep 08, 2026 | 164.25 | 164.25 | 164.25 | 164.25 | 39152.00 |
| Sep 04, 2026 | 164.25 | 164.25 | 164.25 | 164.25 | 114.00 |
| Sep 03, 2026 | 164.25 | 164.25 | 164.25 | 164.25 | 3983.00 |
| Sep 02, 2026 | 156.80 | 156.80 | 156.80 | 156.80 | 236.00 |
| Sep 01, 2026 | 158.07 | 164.62 | 158.07 | 162.10 | 802.00 |
| Aug 31, 2026 | 145.01 | 145.01 | 145.01 | 145.01 | 385.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 52.51 |
| Addex Therapeutics Ltd. | 3.18 |
| Oculis Holding AG | 8.72 |
| Sandoz Group AG | 84.55 |
| Galderma Group AG | 38.91 |
Price Related Metrics
| PE Ratio | 20.30 |
| PS Ratio | 4.728 |
| Price to Book Value | 5.928 |
| Price to Free Cash Flow | 17.06 |
| Earnings Yield | 4.93% |
| Market Cap | 246.26B |
| Operating PE Ratio | 15.98 |
| Normalized PE Ratio | 18.92 |